Tectonic Therapeutic, Inc. (TECX)
NASDAQ: TECX · Real-Time Price · USD
30.37
-1.24 (-3.92%)
Jul 24, 2026, 4:00 PM EDT - Market closed
Tectonic Therapeutic Market Cap
Tectonic Therapeutic has a market cap or net worth of $573.06 million as of July 24, 2026. Its market cap has increased by 33.90% in one year.
Market Cap
573.06M
Enterprise Value
340.80M
1-Year Change
33.90%
Ranking
Category
Stock Price
$30.37
ChartMarket Cap Chart
Since June 21, 2024, Tectonic Therapeutic's market cap has increased from $250.63M to $573.06M, an increase of 128.65%. That is a compound annual growth rate of 48.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 573.06M | 46.78% |
| Dec 31, 2025 | 390.42M | -42.68% |
| Dec 31, 2024 | 681.13M | 171.77% |
| Jun 21, 2024 | 250.63M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AgomAb Therapeutics NV | 616.09M |
| Nuvectis Pharma | 608.76M |
| Immix Biopharma | 606.54M |
| Allogene Therapeutics | 600.57M |
| REGENXBIO | 600.37M |
| ARS Pharmaceuticals | 589.86M |
| Shattuck Labs | 569.74M |
| Zevra Therapeutics | 563.07M |